nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of the hypothalamic-pituitary-adrenal axis in obesity: Cause or consequence?
|
Walker, Brian R |
|
2001 |
11 |
S1 |
p. S91-S95 5 p. |
artikel |
2 |
Adiposity in adult growth hormone deficiency:prediction factor of growth hormone replacement dosage?
|
Boquete, H. |
|
2001 |
11 |
S1 |
p. S142- 1 p. |
artikel |
3 |
Association between hypopituitarism and otherchronic conditions — epilepsy, diabetes mellitus, coronary heart disease and psychiatric illness
|
Lane, H. |
|
2001 |
11 |
S1 |
p. S150- 1 p. |
artikel |
4 |
Benefit of growth hormone (GH) in GH-deficient adults after long-term substitution: Are there parameters influencing response?
|
Pavel, M. |
|
2001 |
11 |
S1 |
p. S126- 1 p. |
artikel |
5 |
Body composition and glucose metabolism in patients with active and inactive acromegaly
|
Herrmann, B. |
|
2001 |
11 |
S1 |
p. S138- 1 p. |
artikel |
6 |
Bone mineral density and parameters of bonemetabolism in patients with acromegaly
|
Góth, M.I. |
|
2001 |
11 |
S1 |
p. S137- 1 p. |
artikel |
7 |
Cancer and the potential place for growth hormone receptor antagonist therapy
|
Friend, Keith E. |
|
2001 |
11 |
S1 |
p. S121-S123 3 p. |
artikel |
8 |
Clinical implications of pulsatile hormone signals
|
Hauffa, Berthold P. |
|
2001 |
11 |
S1 |
p. S1-S8 8 p. |
artikel |
9 |
Comparison of long-term growth in Japanese children on peritoneal dialysis with and without growth hormone therapy
|
Wada, N. |
|
2001 |
11 |
S1 |
p. S155- 1 p. |
artikel |
10 |
Does growth hormone replacement therapy in adult growth hormone-deficient patients result in recurrence of, or increase in size of, pituitary tumours?
|
Wright, J.E. |
|
2001 |
11 |
S1 |
p. S139- 1 p. |
artikel |
11 |
Do the right patients remain in growth hormone treatment — a six-year follow-up study of a growth hormone-deficient adult cohort
|
Viikari, J. |
|
2001 |
11 |
S1 |
p. S129- 1 p. |
artikel |
12 |
Effect of two weeks of growth hormonetreatment in burn patients on conservative management
|
Dash, R.J. |
|
2001 |
11 |
S1 |
p. S152-S153 2 p. |
artikel |
13 |
Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate
|
Beentjes, J.A.M. |
|
2001 |
11 |
S1 |
p. S134- 1 p. |
artikel |
14 |
Effects of reduction of free fatty acids ongrowth hormone (GH)-releasing hormone-stimulated GH release in adults after pituitary surgery
|
van Dam, P.S. |
|
2001 |
11 |
S1 |
p. S125- 1 p. |
artikel |
15 |
Effects of 7 years of growth hormone (GH)therapy in GH-deficient adults with insulin sensitivity
|
Svensson, J. |
|
2001 |
11 |
S1 |
p. S130- 1 p. |
artikel |
16 |
Experience with pegvisomant in the treatment of acromegaly
|
Drake, William M. |
|
2001 |
11 |
S1 |
p. S111-S114 4 p. |
artikel |
17 |
Findings and theoretical considerations on the usefulness of the acid-labile subunit in the monitoring of acromegaly
|
Morrison, Katherine M. |
|
2001 |
11 |
S1 |
p. S61-S63 3 p. |
artikel |
18 |
Foreword
|
Brummer, Robert-Jan |
|
2001 |
11 |
S1 |
p. iii- 1 p. |
artikel |
19 |
Ghrelin induces expression of the immediateearly genes c-Fos and Egr-1 in the hypothalamic arcuate nucleus: a comparison between fasted and fed rats
|
Hewson, A.K. |
|
2001 |
11 |
S1 |
p. S160- 1 p. |
artikel |
20 |
Ghrelin, the endogenous ligand to the growth hormone secretagogue receptor — expression in human hypothalamus and pituitary
|
Korbonits, M. |
|
2001 |
11 |
S1 |
p. S141- 1 p. |
artikel |
21 |
Growth hormone and exercise: Physiology, use and abuse
|
Jenkins, Paul J. |
|
2001 |
11 |
S1 |
p. S71-S77 7 p. |
artikel |
22 |
Growth hormone and insulin-like growth factorI have differential effects on osteoprotegerin and osteoprotegerin ligand gene expression in the human osteoblast cell line MG-63
|
Kim, B.-J. |
|
2001 |
11 |
S1 |
p. S158- 1 p. |
artikel |
23 |
Growth hormone receptorantagonists: Discovery and potential uses
|
Kopchick, John J. |
|
2001 |
11 |
S1 |
p. S103-S109 7 p. |
artikel |
24 |
Growth hormone stimulates synthesis of mannan-binding lectin
|
Hansen, T.K. |
|
2001 |
11 |
S1 |
p. S131- 1 p. |
artikel |
25 |
Growth hormone treatment in adults:Is there a true gender difference?
|
Conceição, Flávia Lucia |
|
2001 |
11 |
S1 |
p. S43-S48 6 p. |
artikel |
26 |
Hospital usage by patients withhypopituitarism
|
Ogunko, A. |
|
2001 |
11 |
S1 |
p. S132- 1 p. |
artikel |
27 |
Impaired tissue perfusion and vascular reactivity in growth hormone-deficient adults is normalized on growth hormone replacement
|
Hána, V. |
|
2001 |
11 |
S1 |
p. S149- 1 p. |
artikel |
28 |
Impaired vascular reactivity in adults withgrowth hormone deficiency: Evidence of a relationship between endothelial dysfunction and arterial stiffness
|
Smith, J.C. |
|
2001 |
11 |
S1 |
p. S148- 1 p. |
artikel |
29 |
Influence of hypothyroidism on hypothalamicpituitary growth hormone regulatory systems
|
Miki, N. |
|
2001 |
11 |
S1 |
p. S133- 1 p. |
artikel |
30 |
Insulin is a more important predictor for leptin than insulin-like growth factor-binding protein 1 and growth hormone
|
Bülow, B. |
|
2001 |
11 |
S1 |
p. S147- 1 p. |
artikel |
31 |
Insulin-like growth factor 1 and growthhormone-releasing hormone (GHRH) inhibit GHRH receptor gene expression in cultured rat pituitary cells
|
Ono, M. |
|
2001 |
11 |
S1 |
p. S157- 1 p. |
artikel |
32 |
Insulin-like growth factor 1 in a normal adult population, in growth hormone deficiency and in acromegaly: Comparison of an automated system with radioimmunoassay
|
Alexopoulou, O. |
|
2001 |
11 |
S1 |
p. S140- 1 p. |
artikel |
33 |
Insulin-like growth factor 1 levels within the first year of growth hormone replacement therapy are higher in married men than in single men treated at the same dose
|
Lahner, H. |
|
2001 |
11 |
S1 |
p. S135- 1 p. |
artikel |
34 |
Insulin signalling through ultradian oscillations
|
Levy, Jonathan C. |
|
2001 |
11 |
S1 |
p. S17-S23 7 p. |
artikel |
35 |
Is there a medical need to explore the clinical use of insulin-like growth factor I?
|
Savage, Martin O. |
|
2001 |
11 |
S1 |
p. S65-S69 5 p. |
artikel |
36 |
Leptin and growth hormone during weight loss in severe obesity
|
Cardoso, M.H. |
|
2001 |
11 |
S1 |
p. S145- 1 p. |
artikel |
37 |
Leptin in adult growth hormone deficiency: Changes with growth hormone replacement are independent of alterations in body fat mass
|
Ahmad, A.M. |
|
2001 |
11 |
S1 |
p. S143- 1 p. |
artikel |
38 |
Long-term effects of growth hormone (GH) replacement therapy on the body composition of adults with GH deficiency: A 60-month follow-up
|
Troendle, A. |
|
2001 |
11 |
S1 |
p. S127- 1 p. |
artikel |
39 |
Modulation of retinal endothelial cell behaviour by insulin-like growth factor 1 and somatostatin analogues: Implications for diabetic retinopathy
|
Wilson, Sylvia H. |
|
2001 |
11 |
S1 |
p. S53-S59 7 p. |
artikel |
40 |
Neurophysiological regulation andtarget-tissue impact of the pulsatile mode of growth hormone secretion in the human
|
Veldhuis, Johannes D. |
|
2001 |
11 |
S1 |
p. S25-S37 13 p. |
artikel |
41 |
Obesity: A rational target for managing diabetes mellitus
|
Mooradian, Arshag D |
|
2001 |
11 |
S1 |
p. S79-S83 5 p. |
artikel |
42 |
Overview of pulse actions in the human
|
Albers, Norbert |
|
2001 |
11 |
S1 |
p. S39-S42 4 p. |
artikel |
43 |
Potential use of growth hormonereceptor antagonist in the treatment of diabetic kidney disease
|
Flyvbjerg, Allan |
|
2001 |
11 |
S1 |
p. S115-S119 5 p. |
artikel |
44 |
Reduced angiogenesis and decreased COX-2 expression in colorectal neoplasia in acromegaly
|
Bustin, S.A. |
|
2001 |
11 |
S1 |
p. S136- 1 p. |
artikel |
45 |
Reduced growth hormone response to growthhormone-releasing hormone combined with arginine in patients with the metabolic syndrome
|
Herrmann, B. |
|
2001 |
11 |
S1 |
p. S146- 1 p. |
artikel |
46 |
Regulation of gonadotropinmreleasing hormone release by cyclic AMP signalling pathways
|
Weiner, Richard I. |
|
2001 |
11 |
S1 |
p. S9-S15 7 p. |
artikel |
47 |
Risk factors for short stature at 6 years of age in children of very low birthweight (< 1500 g)
|
Takahashi, A. |
|
2001 |
11 |
S1 |
p. S154- 1 p. |
artikel |
48 |
Stimulation of liver growth by the tumournecrosis factor receptor 1-interleukin-6-deficient axis in mice
|
Walienius, V.R. |
|
2001 |
11 |
S1 |
p. S156- 1 p. |
artikel |
49 |
Study of the relationship between abdominalobesity, insulin sensitivity and enzyme activity of 11β-hydroxysteroid dehydrogenase during growth hormone treatment
|
Koranyi, J. |
|
2001 |
11 |
S1 |
p. S144- 1 p. |
artikel |
50 |
Sustained and favourable effects of 5 years of growth hormone replacement in adults on metabolic indices, body composition and muscle strength
|
Götherström, G. |
|
2001 |
11 |
S1 |
p. S128- 1 p. |
artikel |
51 |
The influence of an elementary diet on spontaneous growth hormone secretion in paediatric patients with Crohn's disease
|
Böhles, H. |
|
2001 |
11 |
S1 |
p. S151- 1 p. |
artikel |
52 |
The results of replacement therapy in patients with growth hormone deficiency
|
Košt'álová, L. |
|
2001 |
11 |
S1 |
p. S159- 1 p. |
artikel |
53 |
The role of leptin and hypothalamicneuropeptides in energy homeostasis: Update on leptin in obesity
|
Mantzoros, Christos S. |
|
2001 |
11 |
S1 |
p. S85-S89 5 p. |
artikel |
54 |
The somatomedin hypothesis revisited in a transgenic model
|
Isaksson, Olle |
|
2001 |
11 |
S1 |
p. S49-S52 4 p. |
artikel |
55 |
Visceral obesity and the role of the somatotropic axis in the development of metabolic complications
|
Franco, Celina |
|
2001 |
11 |
S1 |
p. S97-S102 6 p. |
artikel |